Loading Pathway...
Error: Pathway image not found.
Hide
Pathway Description
Phenoxymethylpenicillin Action Pathway
Clostridium perfringens (strain 13 / Type A)
Category:
Metabolite Pathway
Sub-Category:
Drug Action
Created: 2023-03-20
Last Updated: 2023-10-25
Phenoxymethylpenicillin (Penicillin V) is a penicillin antibiotic used to prevent and treat mild to moderately severe infections in the respiratory tract, skin, and soft tissues. It is indicated for the treatment of mild to moderately severe infections due to penicillin G¬-sensitive microorganisms, with the use of bacteriological studies (including sensitivity tests) and clinical response. Phenoxymethylpenicillin may be used for the treatment of: 1) mild to moderate infections of the upper respiratory tract, scarlet fever, and mild erysipelas caused by Streptococcus without bacteremia 2) mild to moderately severe infections of the respiratory tract caused by Pneumococcus 3) mild infections of the skin and soft tissues caused by penicillin G-sensitive Staphylococcus 4) mild to moderately severe infections of the oropharynx caused by Fusospirochetosis, including Vincent’s gingivitis and pharyngitis, usually respond to oral penicillin therapy. Phenoxymethylpenicillin inhibits the biosynthesis of cell wall mucopeptide by binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, which are critical in the cell wall synthesis and maintenance, as well as cell division. This disrupts the third and last stage of bacterial cell wall synthesis. This subsequently leads to cell lysis.
References
Phenoxymethylpenicillin Pathway References
National Center for Biotechnology Information (2023). PubChem Compound Summary for CID 6869, Penicillin V. Retrieved March 20, 2023 from https://pubchem.ncbi.nlm.nih.gov/compound/Penicillin-V.
Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, Assempour N, Iynkkaran I, Liu Y, Maciejewski A, Gale N, Wilson A, Chin L, Cummings R, Le D, Pon A, Knox C, Wilson M: DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082. doi: 10.1093/nar/gkx1037
Safrin S (2017). Beta-Lactam & Other Cell Wall- & Membrane-Active Antibiotics. Katzung B.G.(Ed.), Basic & Clinical Pharmacology, 14e. McGraw-Hill. https://accessmedicine-mhmedical-com.login.ezproxy.library.ualberta.ca/content.aspx?bookid=2249§ionid=175223510
Highlighted elements will appear in red.
Highlight Compounds
Highlight Proteins
Enter relative concentration values (without units). Elements will be highlighted in a color gradient where red = lowest concentration and green = highest concentration. For the best results, view the pathway in Black and White.
Visualize Compound Data
Visualize Protein Data
Downloads
Settings